Dr. Jett received his doctorate degree from the University of Missouri in Columbia, Missouri. He completed his internal medicine and pulmonary medicine training at Mayo Graduate School at Mayo Clinic in Rochester, Minnesota. He served for 28 years on the staff of Mayo Clinic, had a joint appointment in medical oncology and pulmonary medicine and rose to the academic rank of professor of medicine. In 2010, he joined the faculty at National Jewish Health in Denver where he was a professor of medicine. His research interest has been in the early detection and screening for lung cancer. His other major interest includes treatment of lung cancer, malignant mesothelioma, and bronchial carcinoid tumors.
Dr. Jett has served on the editorial boards of several major pulmonary medicine journals including Chest and American Journal of Respiratory and Critical Care Medicine. From 2006-2012, he was the editor-in-chief of the Journal of Thoracic Oncology. He is currently the co-editor of the lung cancer section of the premier medical electronic textbook, "UP-TO-DATE."
In 2016 Dr. Jett joined Oncimmune LLC as the chief medical officer and is now co-chief medical officer for Biodesix Inc. The company is involved in developing of blood biomarkers of early detection of cancer.
